1 October 2018 in Journal of Purchasing and Supply Management
1 September 2010 in International Journal of Production Economics
18 April 2016 in Management Research Review
Purpose: Radio-frequency identification (RFID) systems are transforming hospital operations by improving care and reducing costs. However, hospital managers have some concerns about adopting RFID technologies. These are cost, return on investment, privacy and other technology issues. This study examines RFID adoption in health-care industry based on the Technology-Organization-Environment framework. This paper aims to demonstrate how US hospitals are adopting RFID technologies and make recommendations, using empirical data.Design/methodology/approach: An online survey was sent to Chief Information Officers and the top information technology (IT) executives of US acute care hospitals to determine the extent to which hospitals have implemented RFID technologies including the reasons, concerns and applications of RFID technologies, and the antecedents of RFID adoption in hospitals.Findings: The study found that a high percentage of respondents have adopted or are considering adopting RFID technology as a new management tool. Organizational and technological factors have strong positive influence on adoption, whereas environmental factors do not significantly affect the adoption decisions. The main reasons for implementing RFID technology are improved hospital operations, including inventory management, asset control, workflow and patient flow. Some of the concerns are cost of RFID tags and cost associated with implementation.Research limitations/implications: This study is limited to a small sample (n= 86) of US hospitals. This study should continue to be replicated in the future, as adoption of RFID technologies matures in the health-care sector.Originality/value: This study informs health-care managers on the challenges and opportunities of RFID by identifying motivations, barriers and issues related to RFID adoption. The findings of this study will expand the emerging literature and provide direction to academicians for further research in technology adoption.
4 December 2015 in Health Care Management Science
26 March 2017 in Managerial and Decision Economics
12 December 2023 in International Journal of Operations & Production Management
Purpose: The objective of this study is to explore the structural attributes of the pharmaceutical industry before the onset of the COVID-19 pandemic by examining the relationship between inventory and firm performance and developing a taxonomy of pharmaceutical firms based on the earns-turns matrix. Design/methodology/approach: This study examines the inventory–firm performance linkage, considering both total inventory and its discrete inventory components in pharmaceutical firms. In addition, this research develops a new taxonomy of pharmaceutical firms based on the earns-turns matrix. A large panel dataset of firms in the US pharmaceutical industry was collected for the period 2000–2019. Findings: The results reveal that strategic groups identified based on this taxonomy show different levels of profitability and inventory turns in the earns-turns matrix. Most pharmaceutical firms moved from the low-right to the top-left section in the earns-turns matrix, indicating that these firms have generally pursued profitability rather than effective inventory management. Research limitations/implications: This study explores the structural attributes of the pharmaceutical industry using the earns-turns matrix. This two-dimensional analysis may not, however, capture the full complexity of inventory–firm performance dynamics. Practical implications: The mapping of strategic groups on the earns-turns matrix provides a useful tool for visual representations of the dynamics of strategic groups in terms of financial performance and inventory management performance. Practitioners can use the earns-turns matrix to benchmark their firm's position against their competitors. Originality/value: This study broadens the scope of operations management research by introducing the earns-turns matrix as an empirical validation tool for operational and strategic management theories. This study emphasizes the effectiveness of the earns-turns matrix in analyzing strategic groups of pharmaceutical firms.